Burrows of Paragnathia (Crustacea: Isopoda) and bledius (Arthropoda: Staphylinidae) Enhance cliff erosion

In coastal cliffs consisting of Pliocene fine‐grained clastic sediments at El Rompido, Huelva, Spain we discovered around the high water line an extensive zone of about 1.5 m in height burrows that were made by up to 4 mm long isopods Paragnathia formica (Hesse) and small 5 mm long staphylinid beetles (Bledius cf. corniger Rosenhauer). The burrowing zone was crowded with irregular burrows 2–5 mm in diameter and extended some 5 cm deep in the cliff. The base of the cliff showed a clear (bio)erosional notch due to this burrowing activity, comparable to those produced by marine boring and scraping organisms in, for example, calcareous rocks. This indicates that the activity of Paragnathia and Bledius helps in eroding the cliffs, a phenomenon not published earlier as far as we know. A comparable but less extensive burrowed zone was found farther upstream near Cartaya. Their presence around the high tide zone also might prove these burrows to be good markers of former high tide lines in older cliffs.     

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

The discovery of melatonin and its derivatives as antioxidants has stimulated a very large number of studies which have, virtually uniformly, documented the ability of these molecules to detoxify harmful reactants and reduce molecular damage. These observations have clear clinical implications given that numerous age-related diseases in humans have an important free radical component. Moreover, a major theory to explain the processes of aging invokes radicals and their derivatives as causative agents. These conditions, coupled with the loss of melatonin as organisms age, suggest that some diseases and some aspects of aging may be aggravated by the diminished melatonin levels in advanced age. Another corollary of this is that the administration of melatonin, which has an uncommonly low toxicity profile, could theoretically defer the progression of some diseases and possibly forestall signs of aging. Certainly, research in the next decade will help to define the role of melatonin in age-related diseases and in determining successful aging. While increasing life span will not necessarily be a goal of these investigative efforts, improving health and the quality of life in the aged should be an aim of this research.